Zoetis Recommends Pet Owners Protect Their Dogs from Heartworm Disease with New ProHeart® 12 (moxidectin)

Pet Owners Now Have an Innovative Once-Yearly Solution Available to Replace Their Dogs’ Current Monthly Heartworm Dose 

PARSIPPANY, N.J. – Sept. 10, 2019Zoetis is encouraging pet owners to have a “heart to heart” with their veterinarians about protecting their dogs from heartworm disease (caused by Dirofilaria immitis), a potentially life-threatening condition transferred by the bite of an infected mosquito. According to the American Heartworm Society, a dog is a natural host for heartworms, and if untreated, their numbers can increase; dogs have been known to harbor several hundred worms in their bodies.1 Heartworm disease is preventable; however, if proper preventative measures are not in place, it can cause lasting damage to the heart, lungs and arteries, or even death. Dog owners should speak with their veterinarians about ProHeart® 12 (moxidectin), the new once-yearly injection demonstrated to prevent heartworm disease in dogs 12 months of age and older.2

“It only takes one bite from an infected mosquito to spread heartworm disease, so it’s important that every dog owner provides their furry companion consistent, on-time prevention all year long,” said Dr. Robert Gribble, DVM, CVPM, Hallsville Veterinary Hospital, Hallsville, Texas*. “Dog owners should ask their veterinarians about the harmful threat of heartworm disease and if switching to ProHeart 12 for the once-yearly dosing that provides a full year of heartworm disease prevention is the right option for their dog.” 

All dogs are susceptible to heartworm disease regardless of their age, breed or lifestyle as the disease has been found in all 50 states and is a threat all year long – not just during the spring and summer months.3

“As a dog owner as well as a veterinarian, I know how critically important heartworm disease prevention is for my dogs, but remembering monthly dosing is difficult not only for my family but also for many families with pets,” said Claire Walther, DVM, Veterinary Specialty Team, Zoetis Petcare. “ProHeart 12 is a convenient option for dog owners who want the peace of mind that their dogs are protected all year long against this potentially fatal disease.”

Pet owners who want to learn more about heartworm prevention and ProHeart 12 can visit ProHeart.com

About ProHeart 12 
ProHeart 12 is a veterinarian-administered injectable parasiticide for dogs that provides 12 months of heartworm disease prevention, as well as treatment for larval and adult hookworms (Ancylostoma caninum and Uncinaria stenocephala) existing at the time of administration. Just one injection protects dogs against heartworm disease for 12 full months, eliminating the need for monthly dosing.

Use PROHEART 12 in dogs 12 months of age or older. Do not administer to dogs that are sick, debilitated, underweight, have a history of weight loss, or to those previously found to be hypersensitive to the drug. Hypersensitivity reactions may occur in some dogs when PROHEART 12 is administered alone or with vaccines. Anaphylactic and anaphylactoid reactions can result in death and should be treated immediately with the same measures used to treat hypersensitivity reactions to vaccines and other injectable products. The most common reported side effects in clinical trials were vomiting, lethargy, diarrhea, and anorexia. People should avoid inhalation, contact with eyes, or accidental self-injection. Certification is required before veterinarians and staff administer PROHEART 12. See full Prescribing Information for PROHEART 12. 

About Zoetis 
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit www.zoetis.com

For further information contact:
Colleen White

Jamie Siburn

*Dr. Robert Gribble has a consulting relationship with Zoetis.

1Heartworm basics. American Heartworm Society. https://www.heartwormsociety.org/pet-owner-resources/heartworm-basics. Accessed August 9, 2019. 
2ProHeart® 12(moxidectin) for extended-release injectable suspension for dogs. https://www.zoetisus.com/products/dogs/proheart/documents/proheart12-pi.pdf. Accessed August 14, 2019.
3Current canine guidelines for the prevention, diagnosis, and management of heartworm (Dirofilaria immitis) infection in dogs.2018. American Heartworm Society. https://www.heartwormsociety.org/images/pdf/2018-AHS-Canine-Guidelines.pdf. Accessed August 7, 2019.



Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.